Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2017 8
Important citations

Bécue a (2016) emerging fields in fingermark (meta) detection–a critical review. analytical methods.8:7983-8003.

Bécue a (2016)emerging fields in fingermark (meta) detection–a critical review. analytical methods.8 :7983-8003.

Lapierre m, castet-nicolas a, gitenay d, jalaguier s, teyssier c, et al. (2015) expression and role of rip140/nrip1 in chronic lymphocytic leukemia. journal of hematology & oncology.8:20.

Xu j, zhou p, wang w, sun a, guo f (2014) relb, together with rela, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow. journal of molecular medicine.92:77-92.

Hallermann c, atzpodien j, schulze pd (2010) maligne lymphome der hautââ?¬â??update zu diagnostik und therapie. best practice onkologie. 25: 4-21.

Argudo mart�­nez dc. utilidad de la expresi�³n del marcador inmunohistoquimico alk en pacientes con diagn�³stico de linfoma no hodgkin (doctoral dissertation, puce).

Hallermann c, niermann c, fluck m, fischedick ar, schulze hj, et al. (2011) maligne lymphome der haut. der hautarzt. 62: 947-958.

Barth bm, keasey nr, wang x, shanmugavelandy ss, rampal r,et al. (2014)engraftment of human primary acute myeloid leukemia defined by integrated genetic profiling in nod/scid/il2rγnull mice for preclinical ceramide-based therapeutic evaluation.j leuk. 2:2.

Morad sa, davis ts, kester m, loughran tp, cabot mc, et al.(2015) dynamics of ceramide generation and metabolism in response to fenretinide–diversity within and among leukemia. leukemia research.39:1071-1078.

Sun z, wang y, han x, zhao x, peng y, et al.(2015) mir-150 inhibits terminal erythroid proliferation and differentiation. oncotarget.6:43033.

Zhang z, zhang t, zhou y, wei x, zhu j, et al.(2015) activated phosphatidylinositol 3-kinase/akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup o-3a signaling. cellular physiology and biochemistry.35:1643-53.

Rochette l, gudjoncik a, guenancia c, zeller m, cottin y,et al. (2015) the iron-regulatory hormone hepcidin: a possible therapeutic target?. pharmacology & therapeutics.28:35-52.

Grosicki s. (2014) therapy-related acute myeloid leukemia — the risk factors and treatment. hematologia. 5:136-44.

Varella-garcia m, franklin wa, camidge dr. do more with less.

Aisner dl, rumery md, merrick dt, kondo kl, et al.(2016) do more with less: tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the university of colorado experience. archives of pathology & laboratory medicine. 140:1206-20.

Bubolz am, weissinger se, stenzinger a, arndt a, steinestel k, et al.(2014) potential clinical implications of braf mutations in histiocytic proliferations. oncotarget. 5:4060.

Shahjahani m, mohammadiasl j, noroozi f, seghatoleslami m, shahrabi s, et al.(2015) molecular basis of chronic lymphocytic leukemia diagnosis and prognosis. cellular oncology. 38: 93-109.

Robak t, robak p (2013) bcr signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies. international reviews of immunology.32: 358-376.

Жидецкий АВ. Рефолдинг рекомбинантного эктодомена эфринового (2015 рецептора типа А5. В ТРЕХ ЧАСТЯХ.239.

Tomasevic n, luehrsen k, baer m, palath v, martinez d, et al.(2014 )a high affinity recombinant antibody to the human epha3 receptor with enhanced adcc activity. growth factors.32:223-35.

Relevant Topics